Glanbia Raises Annual Profit Forecast as Protein Demand Surges
Nutrition supplement maker Glanbia has raised its full-year profit forecast after strong demand for its protein products boosted first-half earnings. The Irish company now expects adjusted earnings per share to grow between 17% and...
Novo Nordisk Sues Eli Lilly Over Weight-Loss Drug Advertising
Novo Nordisk has filed a lawsuit against rival Eli Lilly in a U.S. federal court, accusing the American pharmaceutical company of misleading advertising by claiming its weight-loss drugs outperform Novo’s treatments. The lawsuit, filed...
Some U.S. Employers Plan to End Coverage of Weight-Loss Drugs as Costs Continue to Rise
Large employers in the United States are increasingly reconsidering coverage for GLP-1 weight-loss medications such as Wegovy, Zepbound, and Foundayo as growing demand continues to drive healthcare costs higher. According to recent surveys, around...